AMH/MIS: What we know already about the gene, the protein and its regulation

Molecular and Cellular Endocrinology

Volumn 211, Issue 1-2, 2003, Pages 21-31

  Rey, Rodolfo ^a,b   Lukas Croisier, Céline ^c,d   Lasala, Celina ^a   Bedecarrás, Patricia ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c ECOLE NORMALE SUPÉRIEURE   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Anti M llerian hormone; Granulosa cells; M llerian inhibiting substance; Ovary; Sertoli cells; Sex differentiation; Testicular hormones

Indexed keywords

DAXX PROTEIN; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; TRANSCRIPTION FACTOR GATA 1; WT1 PROTEIN;

BIRD; CELL SPECIFICITY; CONFERENCE PAPER; DOWN REGULATION; FOLLITROPIN RELEASE; GENE EXPRESSION REGULATION; GERM CELL; GRANULOSA CELL; HORMONAL REGULATION; MEIOSIS; NONHUMAN; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS REGULATION; REPTILE; SEMINAL PLASMA; SEMINIFEROUS TUBULE EPITHELIUM; SERTOLI CELL; SEX DIFFERENCE; SEX HORMONE DETERMINATION; TESTIS; TESTIS FUNCTION;

EID: 0344946482     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.09.007     Document Type: Conference Paper

References (128)

1. Al-Attar L., Noël K., Dutertre M., Belville C., Forest M.G., Burgoyne P.S., Josso N., Rey R. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J. Clin. Invest. 100:1997;1335-1343.
2. Appert A., Fridmacher V., Locquet O., Magre S. Patterns of keratins 8, 18 and 19 during gonadal differentiation in the mouse: sex- and time-dependent expression of keratin 19. Differentiation. 63:1998;273-284.
3. Arango N.A., Lovell-Badge R., Behringer R.R. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell. 99:1999;409-419.
4. Baarends W.M., van Helmond M.J., Post M., van der Schoot P.J., Hoogerbrugge J.W., De Winter J.P., Uilenbroek J.T., Karels B., Wilming L.G., Meijers J.H. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development. 120:1994;189-197.
5. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development. the estrous cycle. and gonadotropin-induced follicle growth. Endocrinology. 136:1995;4951-4962.
6. Beau C., Rauch M., Joulin V., Jégou B., Guerrier D. GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse. Mol. Reprod. Dev. 56:2000;124-138.
7. Beau C., Vivian N., Münsterberg A., Dresser D.W., Lovell-Badge R., Guerrier D. In vivo analysis of the regulation of the anti-Müllerian hormone, as a marker of Sertoli cell differentiation during testicular development, reveals a multi-step process. Mol. Reprod. Dev. 59:2001;256-264.
8. Behringer R.R., Cate R.L., Froelick G.J., Palmiter R.D., Brinster R.L. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance. Nature. 345:1990;167-170.
9. Behringer R.R., Finegold M.J., Cate R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell. 79:1994;415-425.
10. Belville C., Josso N., Picard J.Y. Persistence of Müllerian derivatives in males. Am. J. Med. Genet. 89:1999;218-223.
11. Bézard J., Vigier B., Tran D., Mauleon P., Josso N. Immunocytochemical study of anti-Müllerian hormone in sheep ovarian follicles during fetal and post-natal development. J. Reprod. Fertil. 80:1987;509-516.
12. Blagosklonova O., Joanne C., Roux C., Bittard H., Fellmann F., Bresson J.L. Absence of anti-Müllerian hormone (AMH) and M2A immunoreactivities in Sertoli cell-only syndrome and maturation arrest with and without AZF microdeletions. Hum. Reprod. 17:2002;2062-2065.
13. Budzik G.P., Swann D.A., Hayashi A., Donahoe P.K. Enhanced purification of Müllerian inhibiting substance by lectin affinity chromatography. Cell. 21:1980;909-915.
14. Budzik G.P., Powell S.M., Kamagata S., Donahoe P.K. Müllerian inhibiting substance fractionation by dye affinity chromatography. Cell. 34:1983;307-314.
15. Carré-Eusèbe D., di Clemente N., Rey R., Pieau C., Vigier B., Josso N., Picard J.Y. Cloning and expression of the chick anti-Müllerian hormone gene. J. Biol. Chem. 271:1996;4798-4804.
16. Carré-Eusèbe D., Oréal E., Di Clemente N., Rey R., Josso N., Picard J.Y., 1997. The chick anti-Müllerian hormone gene. In: Harvey, S. (Ed.), Perspectives in Avian Endocrinology. Journal of Endocrinology Ltd., Bristol, UK, pp. 15-26.
17. Cate R.L., Mattaliano R.J., Hession C., Tizard R., Farber N.M., Cheung A., Ninfa E.G., Frey A.Z., Gash D.J., Chow E.P., Fisher R.A., Bertonis J.M., Torres G., Wallner B.P., Ramachandran K.L., Ragin R.C., Manganaro T.F., MacLaughlin D.T., Donahoe P.K. Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 45:1986;685-698.
18. Clarke T.R., Hoshiya Y., Yi S.E., Liu X., Lyons K.M., Donahoe P.K. Müllerian Inhibiting Substance signaling uses a Bone Morphogenetic Protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression. Mol. Endocrinol. 15:2001;946-959.
19. Cohen-Haguenauer O., Picard J.Y., Mattei M.G., Serero S., Nguyen V.C., de Tand M.F., Guerrier D., Hors-Cayla M.C., Josso N., Frézal J. Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenet. Cell Genet. 44:1987;2-6.
20. Cook C.L., Siow Y., Taylor S., Fallat M.E. Serum Müllerian inhibiting substance levels during normal mestrual cycles. Fertil. Steril. 73:2000;859-861.
21. Cook C.L., Siow Y., Brenner A.G., Fallat M.E. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil. Steril. 77:2002;141-146.
22. s( gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J. Clin. Endocrinol. Metab. 86:2001;1778-1881.
23. de Santa Barbara P., Bonneaud N., Boizet B., Desclozeaux M., Moniot B., Sudbeck P., Scherer G., Poulat F., Berta P. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol. Cell. Biol. 18:1998;6653-6665.
24. de Vet A., Laven J.S., De Jong F.H., Themmen A.P., Fauser B.C. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil. Steril. 77:2002;357-362.
25. di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol. Endocrinol. 8:1994;1006-1020.
26. Donahoe P.K., Ito Y., Marfatia S., Hendren W.H. III The production of müllerian inhibiting substance by the fetal, neonatal and adult rat. Biol. Reprod. 15:1976;329-334.
27. Donahoe P.K., Ito Y., Morikawa Y., Hendren W.H. III Müllerian inhibiting substance in human testes after birth. J. Pediatr. Surg. 12:1977a;323-330.
28. Donahoe P.K., Ito Y., Price J.M., Hendren W.H. III Müllerian inhibiting substance activity in bovine fetal, newborn and prepubertal testes. Biol. Reprod. 16:1977;238-243.
29. Dresser D.W., Hacker A., Lovell B., Guerrier D. The genes for a spliceosome protein (SAP62) and the anti-Müllerian hormone (AMH) are contiguous. Hum. Mol. Genet. 4:1995;1613-1618.
30. Dutertre M., Rey R., Porteu A., Josso N., Picard J.Y. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor. Mol. Cell Endocrinol. 136:1997;57-65.
31. Fallat M.E., Siow Y., Belker A.M., Boyd J.K., Yoffe S., MacLaughlin D.T. The presence of müllerian inhibiting substance in human seminal plasma. Hum. Reprod. 11:1996;2165-2169.
32. Fallat M.E., Siow Y., Marra M., Cook C., Carrillo A. Müllerian- inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil. Steril. 67:1997;962-965.
33. Fénichel P., Rey R., Poggioli S., Donzeau M., Chevallier D., Pointis G. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum. Reprod. 14:1999;2020-2024.
34. Fröjdman K., Pelliniemi L.J., Rey R., Virtanen I. Presence of anti-Müllerian hormone correlates with absence of laminin α5 chain in differentiating rat testis and ovary. Histochem. Cell Biol. 111:1999;367-373.
35. Fujisawa M., Yamasaki T., Okada H., Kamidono S. The significance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis. Hum. Reprod. 17:2002;968-970.
36. Gao Q., Womack J.E. A genetic map of bovine chromosome 7 with an interspecific hybrid backcross panel. Mamm. Genome. 8:1997;258-261.
37. Gouédard L., Chen Y.G., Thevenet L., Racine C., Borie S., Lamarre I., Josso N., Massagué J., di Clemente N. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J. Biol. Chem. 275:2000;27973-27978.
38. Guerrier D., Boussin L., Mader S., Josso N., Kahn A.J.Y., Picard J.Y. Expression of the gene for anti-Müllerian hormone. J. Reprod. Fertil. 88:1990;695-706.
39. Gustafson M.L., Lee M.M., Scully R.E., Moncure A.C., Hirakawa T., Goodman A., Muntz H.G., Donahoe P.K., MacLaughlin D.T., Fuller A.F. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N. Engl. J. Med. 326:1992;466-471.
40. Haqq C., Lee M.M., Tizard R., Wysk M., DeMarinis J., Donahoe P.K., Cate R.L. Isolation of the rat gene for Müllerian inhibiting substance. Genomics. 12:1992;665-669.
41. Haqq C.M., King C.Y., Donahoe P.K., Weiss M.A. SRY recognizes conserved DNA sites in sex-specific promoters. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1097-1101.
42. Haqq C.M., King C.Y., Ukiyama E., Falsafi S., Haqq T.N., Donahoe P.K., Weiss M.A. Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY. Science. 266:1994;1494-1500.
43. Hayashi H., Shima H., Hayashi K., Trelstad R.L., Donahoe P.K. Immunocytochemical localization of Müllerian inhibiting substance in the rough endoplasmic reticulum and Golgi apparatus in Sertoli cells of the neonatal calf testis using a monoclonal antibody. J. Histochem. Cytochem. 32:1984;649-654.
44. Hirobe S., He W.W., Lee M.M., Donahoe P.K. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology. 131:1992;854-862.
45. Hirobe S., He W.W., Gustafson M.L., MacLaughlin D.T., Donahoe P.K. Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol. Reprod. 50:1994;1238-1243.
46. Hutson J.M., Donahoe P.K. Is Müllerian-inhibiting substance a circulating hormone in the chick-quail chimera? Endocrinology. 113:1983;1470-1475.
47. Hudson P.L., Dougas I., Donahoe P.K., Cate R.L., Epstein J., Pepinsky R.B., MacLaughlin D.T. An immunoassay to detect human Müllerian inhibiting substance in males and females during normal development. J. Clin. Endocrinol. Metab. 70:1990;16-22.
48. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat. Genet. 32:2002;408-410.
49. Josso N. Permeability of membranes to the Müllerian-inhibiting substance synthesized by the human fetal testis in vitro: a clue to its biochemical nature. J. Clin. Endocrinol. Metab. 34:1972;265-270.
50. Josso N. In vitro synthesis of Müllerian-inhibiting hormone by seminiferous tubules isolated from the calf fetal testis. Endocrinology. 93:1973;829-834.
51. Josso N., Di Clemente N. Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol. Metab. 14:2003;91-97.
52. Josso N., Picard J.Y., Dacheux J.L., Courot M. Detection of anti-Müllerian activity in boar rete testis fluid. J. Reprod. Fertil. 57:1979;397-400.
53. Josso N., Legeai L., Forest M.G., Chaussain J.L., Brauner R. An enzyme linked immunoassay for anti-Müllerian hormone: a new tool for the evaluation of testicular function in infants and children. J. Clin. Endocrinol. Metab. 70:1990;23-27.
54. Josso N., Cate R.L., Picard J.Y., Vigier B., di Clemente N., Wilson C., Imbeaud S., Pepinsky R.B., Guerrier D., Boussin L., Legeai L., Carré-Eusèbe D. Anti-Müllerian hormone, the Jost factor. Recent Prog. Horm. Res. 48:1993;1-59.
55. Josso N., Lamarre I., Picard J.Y., Berta P., Davies N., Morichon N., Peschanski M., Jeny R. Anti-Müllerian hormone in early human development. Early Hum. Dev. 33:1993a;91-99.
56. Josso N., di Clemente N., Gouédard L. Anti-Müllerian hormone and its receptors. Mol. Cell. Endocrinol. 179:2001;25-32.
57. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog. Horm Res. 8:1953;379-418.
58. King T.R., Lee B.K., Behringer R.R., Eicher E.M. Mapping anti-Mullerian hormone (Amh) and related sequences in the mouse: identification of a new region of homology between MMU10 and HSA19p. Genomics. 11:1991;273-283.
59. Kuroda T., Lee M.M., Haqq C.M., Powell D.M., Manganaro T.F., Donahoe P.K. Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology. 127:1990;1825-1832.
60. Lahbib-Mansais Y., Barbosa A., Yerle M., Parma P., Milan D., Pailhoux E., Gellin J., Cotinot C. Mapping in pig of genes involved in sexual differentiation: AMH WT1. FTZF1. SOX2. SOX9. AHC. and placental and embryonic CYP19. Cytogenet. Cell Genet. 76:1997;109-114.
61. Lane A.H., Lee M.M., Fuller A.F.J., Kehas D.J., Donahoe P.K., MacLaughlin D.T. Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol. Oncol. 73:1999;51-55.
62. Lee M.M., Cate R.L., Donahoe P.K., Waneck G.L. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for mullerian inhibiting substance. Endocrinology. 130:1992a;847-853.
63. Lee M.M., Donahoe P.K., Hasegawa T., Silverman B., Crist G.B., Best S., Hasegawa Y., Noto R.A., Schoenfeld D., MacLaughlin D.T. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81:1996;571-576.
64. Long W.Q., Ranchin V., Pautier P., Belville C., Denizot P., Cailla H., Lhommé C., Picard J.Y., Bidart J.M., Rey R. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 85:2000;540-544.
65. Lukas-Croisier C., Lasala C., Nicaud J., Bedecarrás P., Kumar T.R., Dutertre M., Matzuk M.M., Picard J.Y., Josso N., Rey R., 2003. Follicle stimulating hormone increases testicular anti-Müllerian hormone (AMH) production through Sertoli cell proliferation and a non-classical cyclic AMP-mediated activation of the AMH gene. Mol Endocrinol, in press.
66. Marshall W.A., Tanner J.M. Variation in pattern of pubertal changes in boys. Arch. Dis. Child. 44:1969;291-303.
67. Maymon B.B., Yogev L., Paz G., Kleiman S.E., Schreiber L., Botchan A., Hauser R., Yavetz H. Sertoli cell maturation in men with azoospermia of different etiologies. Fertil. Steril. 77:2002;904-909.
68. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10:1996;2577-2587.
69. Morais da Silva S., Hacker A., Harley V., Goodfellow P., Swain A., Lovell-Badge R. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat. Genet. 14:1996;62-67.
70. Morel Y., Rey R., Teinturier C., Nicolino M., Michel-Calemard L., Mowszowicz I., Jaubert F., Fellous M., Chaussain J.L., Chatelain P., David M., Nihoul F., Forest M.G., Josso N. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur. J. Pediatr. 161:2002;49-59.
71. Morikawa N., Clarke T.R., Novina C.D., Watanabe K., Haqq C., Weiss M., Roy A.L., Donahoe P.K. Human Müllerian inhibiting substance promoter contains a functional TFII-I-binding initiator. Biol. Reprod. 63:2000;1075-1083.
72. Mudgett-Hunter M., Budzik G.P., Sullivan M., Donahoe P.K. Monoclonal antibody to Müllerian inhibiting substance. J. Immunol. 128:1982;1327-1333.
73. Münsterberg A., Lovell-Badge R. Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development. 113:1991;613-624.
74. Nachtigal M.W., Ingraham H.A. Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7711-7716.
75. Nachtigal M.W., Hirokawa Y., Enyeart-VanHouten D.L., Flanagan J.N., Hammer G.D., Ingraham H.A. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:1998;445-454.
76. Neeper M., Lowe R., Galuska S., Hoffmann K.J., Smith R.G., Elbrecht A. Molecular cloning of an avian anti-Müllerian hormone homologue. Gene. 176:1996;203-209.
77. Oréal E., Pieau C., Mattei M.G., Josso N., Picard J.Y., Carré-Eusèbe D., Magre S. Early expression of AMH in chicken embryonic gonads precedes testicular SOX9 expression. Dev. Dyn. 212:1998;522-532.
78. Pasqualini T., Chemes H., Rivarola M.A. Testicular testosterone levels during puberty in cryptorchidism. Clin. Endocrinol. (Oxf). 15:1981;545-554.
79. Pelliniemi L.J., Fröjdman K. Structural and regulatory macromolecules in sex differentiation of gonads. J. Exp. Zool. 290:2001;523-528.
80. Pepinsky R.B., Sinclair L.K., Chow E.P., Mattaliano R.J., Manganaro T.F., Donahoe P.K., Cate R.L. Proteolytic processing of Müllerian inhibiting substance produces a transforming growth factor-β-like fragment. J. Biol. Chem. 263:1988;18961-18965.
81. Picard J.Y., Josso N. Hormone anti-müllérienne et lectines: nouvelles perspectives. Ann. Endocrinol. 41:1980;538-544.
82. Picard J.Y., Josso N. Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor. Mol. Cell Endocrinol. 34:1984;23-29.
83. Picard J.Y., Tran D., Josso N. Biosynthesis of labelled anti-Müllerian hormone by fetal testes: evidence for the glycoprotein nature of the hormone and for its disulfide-bonded structure. Mol. Cell Endocrinol. 12:1978;17-30.
84. Picard J.Y., Benarous R., Guerrier D., Josso N., Kahn A. Cloning and expression of cDNA for anti-Müllerian hormone. Proc. Natl. Acad. Sci. U.S.A. 83:1986a;5464-5468.
85. Picard J.Y., Goulut C., Bourrillon R., Josso N. Biochemical analysis of bovine testicular anti-Müllerian hormone. FEBS Lett. 195:1986b;73-76.
86. Picon R. Action du testicule foetal sur le développement in vitro des canaux de Müller chez le rat. Arch. Anat. Microsc. Morphol. Exp. 58:1969;1-19.
87. Rajpert-De Meyts E., Jørgensen N., Græm N., Müller J., Cate R.L., Skakkebæk N.E. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J. Clin. Endocrinol. Metab. 84:1999;3836-3844.
88. Rey R., Josso N. Regulation of testicular anti-Müllerian hormone secretion. Eur. J. Endocrinol. 135:1996;144-152.
89. Rey R., Lordereau-Richard I., Carel J.C., Barbet P., Cate R.L., Roger M., Chaussain J.L., Josso N. Anti-müllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development. J. Clin. Endocrinol. Metab. 77:1993;1220-1226.
90. Rey R., Mebarki F., Forest M.G., Mowszowicz I., Cate R.L., Morel Y., Chaussain J.L., Josso N. Anti-müllerian hormone in children with androgen insensitivity. J. Clin. Endocrinol. Metab. 79:1994;960-964.
91. Rey R., Al-Attar L., Louis F., Jaubert F., Barbet P., Nihoul-Fékété C., Chaussain J.L., Josso N. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am. J. Pathol. 148:1996a;1689-1698.
92. Rey R., Lhommé C., Marcillac I., Lahlou N., Duvillard P., Josso N., Bidart J.M. Anti-Müllerian hormone as a serum marker of granulosa-cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am. J. Obstet. Gynecol. 174:1996b;958-965.
93. Rey R., Belville C., Nihoul-Fékété C., Michel-Calemard L., Forest M.G., Lahlou N., Jaubert F., Mowszowicz I., David M., Saka N., Bouvattier C., Bertrand A.M., Lecointre C., Soskin S., Cabrol S., Crosnier H., Léger J., Lortat-Jacob S., Nicolino M., Rabl W., Toledo S.P., Bas F., Gompel A., Czernichow P., Josso N. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J. Clin. Endocrinol. Metab. 84:1999;627-631.
94. Rey R., Sabourin J.C., Venara M., Long W.Q., Jaubert F., Zeller W.P., Duvillard P., Chemes H., Bidart J.M. Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors. Hum. Pathol. 31:2000;1202-1208.
95. Robert N.M., Tremblay J.J., Viger R.S. Friend of GATA (FOG)-1 and FOG-2 differentially repress the GATA-dependent activity of multiple gonadal promoters. Endocrinology. 143:2002;3963-3973.
96. Rota A., Ballarin C., Vigier B., Cozzi B., Rey R. Age dependent changes in plasma anti-Mullerian hormone concentrations in the bovine male, female, and freemartin from birth to puberty: relationship between testosterone production and influence on sex differentiation. Gen. Comp. Endocrinol. 129:2002;39-44.
97. Schwindt B., Doyle L.W., Hutson J.M. Serum levels of müllerian inhibiting substance in preterm and term male neonates. J. Urol. 158:1997;610-612.
98. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., Shelden R.M. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil. Steril. 77:2002;468-471.
99. Shen W.H., Moore C.C., Ikeda Y., Parker K.L., Ingraham H.A. Nuclear receptor steroidogenic factor 1 regulates the Müllerian inhibiting substance gene: a link to the sex determination cascade. Cell. 77:1994;651-661.
100. Shima H., Donahoe P.K., Budzik G.P., Kamagata S., Hudson P., Mudgett-Hunter M. Production of monoclonal antibodies for affinity purification of bovine müllerian inhibiting substance activity. Hybridoma. 3:1984;201-214.
101. Silverman L.A., Gitelman S.E. Immunoreactive inhibin, mullerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors. J. Pediatr. 129:1996;918-921.
102. Smith C.A., Smith M.J., Sinclair A.H. Gene expression during gonadogenesis in the chicken embryo. Gene. 234:1999;395-402.
103. Steger K., Rey R., Kliesch S., Louis F., Schleicher G., Bergmann M. Immunohistochemical detection of immature Sertoli cell markers in testicular tissue of infertile adult men: a preliminary study. Int. J. Androl. 19:1996;122-128.
104. Steger K., Rey R., Louis F., Kliesch S., Behre H.M., Nieschlag E., Hoepffner W., Bailey D., Marks A., Bergmann M. Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum. Reprod. 14:1999;136-143.
105. Stephen A.E., Masiakos P.T., Segev D.L., Vacanti J.P., Donahoe P.K., MacLaughlin D.T. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3214-3219.
106. Stuchi-Perez E.G., Lukas-Croisier C., De Castro M., Baptista M.T., Ribeiro Scolfaro M., Marques-De-Faria A.P., Hackel C., Maciel-Guerra A.T., Guerra Júnior G. Evaluation of the tubular and interstitial functions of the testis in 46,XY patients with ambiguous genitalia. J. Pediatr. Endocrinol. Metab. 13:2000;605-612.
107. Taguchi O., Cunha G.R., Lawrence W.D., Robboy S.J. Timing and irreversibility of Müllerian duct inhibition in the embryonic reproductive tract of the human male. Dev. Biol. 106:1984;394-398.
108. Takahashi M., Hayashi M., Manganaro T.F., Donahoe P.K. The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol. Reprod. 35:1986;447-453.
109. Teixeira J., Maheswaran S., Donahoe P.K. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr. Rev. 22:2001;657-674.
110. Tilmann C., Capel B. Cellular and molecular pathways regulating mammalian sex determination. Recent Prog. Horm. Res. 57:2002;1-18.
111. Tran D., Josso N. Relationship between avian and mammalian anti-Müllerian hormones. Biol. Reprod. 16:1977;267-273.
112. Tran D., Josso N. Localization of anti-Müllerian hormone in the rough endoplasmic reticulum of the developing bovine Sertoli cell using immunocytochemistry with a monoclonal antibody. Endocrinology. 111:1982;1562-1567.
113. Tran D., Meusy-Dessolle N., Josso N. Anti-Müllerian hormone is a functional marker of foetal Sertoli cells. Nature. 269:1977;411-412.
114. Tran D., Meusy-Dessole N., Josso N. Waning of anti-Müllerian activity: an early sign of Sertoli cell maturation in the developing pig. Biol. Reprod. 24:1981;923-931.
115. Tremblay J.J., Viger R.S. Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol. Endocrinol. 13:1999;1388-1401.
116. Tremblay J.J., Viger R.S. Nuclear receptor Dax-1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells. Biol. Reprod. 64:2001;1191-1199.
117. Ueno S., Takahashi M., Manganaro T.F., Ragin R.C., Donahoe P.K. Cellular localization of mullerian inhibiting substance in the developing rat ovary. Endocrinology. 124:1989;1000-1006.
118. Vigier B., Picard J.Y., Josso N. A monoclonal antibody against bovine anti-Müllerian hormone. Endocrinology. 110:1982;131-137.
119. Vigier B., Tran D., du Mesnil du Buisson F., Heyman Y., Josso N. Use of monoclonal antibody techniques to study the ontogeny of bovine anti-Müllerian hormone. J. Reprod. Fertil. 69:1983;207-214.
120. Vigier B., Picard J.Y., Tran D., Legeai L., Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology. 114:1984;1315-1320.
121. Viger R.S., Mertineit C., Trasler J.M., Nemer M. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance promoter. Development. 125:1998;2665-2675.
122. Visser J.A., Olaso R., Verhoef P., Kramer P., Themmen A.P., Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol. Endocrinol. 15:2001;936-945.
123. Voutilainen R., Miller W.L. Human Müllerian inhibitory factor messenger ribonucleic acid is hormonally regulated in the fetal testis and in adult granulosa cells. Mol. Endocrinol. 1:1987;604-608.
124. Wallen J., Cate R.L., Kiefer D.M., Riemen M.W., Martinez D., Hoffman R.M., Donahoe P.K., Von Hoff D.D., Pepinsky B., Oliff A. Minimal anti-proliferative effect of recombinant Müllerian inhibiting substance on gynecological tumor cell lines and tumor explants. Cancer Res. 49:1989;2005-2011.
125. Watanabe K., Clarke T.R., Lane A.H., Wang X., Donahoe P.K. Endogenous expression of Müllerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc. Natl. Acad. Sci. U.S.A. 97:2000;1624-1629.
126. Western P.S., Harry J.L., Graves J.A.M., Sinclair A.H. Temperature-dependent sex determination in the American alligator: AMH precedes SOX9 expression. Dev. Dyn. 216:1999;411-419.
127. Wilson C.A., di Clemente N., Ehrenfels C., Pepinsky R.B., Josso N., Vigier B., Cate R.L. Müllerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily. Mol. Endocrinol. 7:1993;247-257.
128. Young J., Rey R., Couzinet B., Chanson P., Josso N., Schaison G. Antimüllerian hormone in patients with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 84:1999;2696-2699.